Rezq Bio
PrivateLast Round
Accelerator
Jun 15, 2023
Company Overview
Rezq Bio is a biotechnology company that develops dendritic cell therapy for the treatment of Type 1 diabetes and other localized autoimmune conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rezq Bio Comparables
Compare Rezq Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cell4Cure AB | 86% | |
| Avotres Inc. | 85% | |
| SymbioCellTech | 72% |
Rezq Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 15, 2023 |
Rezq Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartUp Health | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 15, 2023
Secured funding from StartUp Health.
Rezq Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rezq Bio's valuation, stock price, and market status.
Is Rezq Bio a public or private company?
Rezq Bio is a private company.
What is the current stock price of Rezq Bio?
Rezq Bio is a private company with no public stock price. Caplight tracks Rezq Bio's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Rezq Bio worth (valuation)?
Valuation information for Rezq Bio is not publicly available.
Can I buy Rezq Bio stock?
Rezq Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rezq Bio's last funding round?
Rezq Bio's most recent funding round was Accelerator on June 15, 2023.
Who are the main investors in Rezq Bio?
Key investors in Rezq Bio include StartUp Health.
Will Rezq Bio IPO soon?
No public IPO plans have been announced for Rezq Bio.
How can I track Rezq Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rezq Bio's secondary market activity and sign up for updates.